Detalles de la búsqueda
1.
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 20(10): 1386-1394, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31427205
2.
Response to post-axitinib treatment in patients with metastatic renal cell carcinoma.
BMC Cancer
; 16: 254, 2016 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27026229
3.
A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma.
J Urol
; 194(2): 297-303, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25813447
4.
A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.
Cancer
; 120(11): 1647-55, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24577874
5.
The Role of Nurses in the Management of Adverse Events in Patients Receiving First-Line Axitinib Plus Immuno-Oncology Agents for Advanced Renal Cell Carcinoma.
Semin Oncol Nurs
; 40(1): 151545, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38008655
6.
Avelumab First-Line Maintenance Therapy: Managing Patients With Advanced Urothelial Carcinoma.
Clin J Oncol Nurs
; 27(1): 71-80, 2023 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37677821
7.
Cessation of vascular endothelial growth factor-targeted therapy in patients with metastatic renal cell carcinoma: feasibility and clinical outcome.
Cancer
; 118(13): 3277-82, 2012 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22139966
8.
Avelumab First-Line Maintenance Treatment in Advanced Bladder Cancer: Practical Implementation Steps for Infusion Nurses.
J Infus Nurs
; 45(3): 142-153, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35537002
9.
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group.
Clin Cancer Res
; 27(9): 2416-2423, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563636
10.
Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.
BJU Int
; 106(9): 1266-9, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20346042
11.
New therapeutic strategies for renal cell carcinoma.
Urol Nurs
; 30(1): 40-53, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20359144
12.
The Critical Role of the Oncology Nurse as a Partner in the Management of Patients With Advanced Kidney Cancer: Toxicity Management, Symptom Control, and Palliative Care.
Cancer J
; 26(5): 460-463, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32947314
13.
Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study Approach.
JCO Oncol Pract
; 16(2_suppl): 15s-19s, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32045538
14.
Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma.
Clin Genitourin Cancer
; 18(6): 429-435, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32800717
15.
Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs).
Oncologist
; 14(3): 291-302, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19276294
16.
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types.
J Adv Pract Oncol
; 10(Suppl 1): 47-62, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014517
17.
Immune Checkpoint Inhibitor Therapy: Key Principles When Educating Patients.
Clin J Oncol Nurs
; 23(3): 271-280, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099804
18.
A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy.
J Immunother Cancer
; 7(1): 127, 2019 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31097024
19.
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors.
Clin Genitourin Cancer
; 17(3): 177-182, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30824360
20.
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC).
J Immunother Cancer
; 7(1): 354, 2019 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31856918